Skip to main content

Mark Crane Joins Gene Logic as VP of Marketing and Business Development; Nicholas Ventresca Leaves Pfizer for Charles River Labs; Microsoft s Bill Brammer Joins VizX Board; PNAS Editor Cozzarelli Dead; and Others

Mark Crane has become vice president of marketing and business development for Gene Logic's preclinical division, the company said last week. Previously, he held positions in sales and marketing at Quest Pharmaceutical Services, MDS Pharma Services, Avantec, and PerkinElmer. At GeneLogic, he will be responsible for sales and marketing of preclinical services to pharmaceutical and biotechnology companies and to government organizations.

Gary Blackburn has become president and chief executive officer of Ohmx, the Evanston, Ill.-based protein biosensor company said on Monday. Most recently, he was director of research and technology at Motorola Clinical Micro Sensors.

Nicholas Ventresca has become corporate senior vice president of information technology as well as chief information officer of Charles River Laboratories, the company said last week. Prior to joining Charles River Labs, Ventresca was vice president in business technology for Pfizer's corporate headquarters in New York and R&D headquarters in New London, Conn.

Bill Brammer has joined the board of directors of VizX Labs, the company said today. He is director of small and mid-market solutions and partner business management at Microsoft.

Frantisek Svec has joined the scientific advisory board of Protein Discovery, the company said last week. He is a researcher at the University of California, Berkeley and the Lawrence Berkeley National Laboratory, where he investigates the synthesis of new separations media for use in conventional and microscale chromatography systems. Svec received a PhD in polymer chemistry and a BS in chemistry from the Institute of Chemical Technology in Prague.

Blaine Bowman has become lead director of Cell Biosciences, the company said last week.

Bowman was most recently president and CEO of Dionex. He holds a BS in physics from Brigham Young University, and an MBA from Stanford University Graduate School of Business.

Nicholas Cozzarelli, editor in chief of PNAS and a professor of molecular and cell biology at the University of California, Berkeley, died on March 19 from complications of treatment for Burkitt's lymphoma. He was 67. Cozzarelli received an undergraduate degree in biology from Princeton University and a PhD in biochemistry from Harvard Medical School.

IO Informatics and the Division of Chemical Information of the American Chemical Society announced the winners of the CINF-IO Informatics Scholarship for Scientific Excellence at the 231st National ACS Meeting in Atlanta last week. The scholarship rewards graduate students for "scientific excellence in chemical information and related sciences," the organizations said in a statement. The winners of this year's award are: Lorant Bodis, Organic Chemistry Laboratory, ETH Z rich; Barun Bhhatarai, Chemistry Department, Clarkson University; Cheng Chang, Department of Pharmaceutics, University of Maryland at Baltimore, Xiao Dong, School of Informatics, Indiana University; and Monika Rella, Institute of Molecular and Cellular Biology, University of Leeds. Each winner received a $1,000 award and a one-year license to IO Informatics' Sentient software.

Promoted? Changing jobs? GenomeWeb News wants to know. E-mail us at [email protected] to announce your move in PEOPLE, a weekly roundup of personnel changes in the genomics industry.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.